146 related articles for article (PubMed ID: 27027711)
1. Quantitative assessment of two methods of tiludronate administration for the treatment of lameness caused by navicular syndrome in horses.
Whitfield CT; Schoonover MJ; Holbrook TC; Payton ME; Sippel KM
Am J Vet Res; 2016 Feb; 77(2):167-73. PubMed ID: 27027711
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of intravenous regional limb perfusion of tiludronate as an adjunctive treatment for lameness caused by navicular syndrome in horses.
Schoonover MJ; Whitfield CT; Young JM; Sippel KM; Payton ME
Am J Vet Res; 2018 Dec; 79(12):1313-1320. PubMed ID: 30457899
[TBL] [Abstract][Full Text] [Related]
3. Quantitative comparison of three commonly used treatments for navicular syndrome in horses.
Schoonover MJ; Jann HW; Blaik MA
Am J Vet Res; 2005 Jul; 66(7):1247-51. PubMed ID: 16111165
[TBL] [Abstract][Full Text] [Related]
4. Tiludronate infusion in the treatment of bone spavin: a double blind placebo-controlled trial.
Gough MR; Thibaud D; Smith RK
Equine Vet J; 2010 Jul; 42(5):381-7. PubMed ID: 20636772
[TBL] [Abstract][Full Text] [Related]
5. Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.
Richbourg HA; Mitchell CF; Gillett AN; McNulty MA
BMC Vet Res; 2018 Mar; 14(1):105. PubMed ID: 29554967
[TBL] [Abstract][Full Text] [Related]
6. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
Erkert RS; MacAllister CG; Payton ME; Clarke CR
Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
[TBL] [Abstract][Full Text] [Related]
7. Tiludronate concentrations and cytologic findings in synovial fluid after intravenous regional limb perfusion with tiludronate in horses.
Hunter BG; Duesterdieck-Zellmer KF; Larson MK
PeerJ; 2015; 3():e889. PubMed ID: 25945303
[TBL] [Abstract][Full Text] [Related]
8. Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double-blind placebo-controlled clinical trial.
Denoix JM; Thibaud D; Riccio B
Equine Vet J; 2003 Jun; 35(4):407-13. PubMed ID: 12880010
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of tiludronate in the treatment of horses with signs of pain associated with osteoarthritic lesions of the thoracolumbar vertebral column.
Coudry V; Thibaud D; Riccio B; Audigié F; Didierlaurent D; Denoix JM
Am J Vet Res; 2007 Mar; 68(3):329-37. PubMed ID: 17331024
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Analysis of the Use of Tiludronate in Equine Practice: Safety on 1804 Horses, Efficacy on 343 Horses.
Tischmacher A; Wilford S; Allen K; Mitchell RD; Parkin T; Denoix JM
J Equine Vet Sci; 2022 Aug; 115():104007. PubMed ID: 35577109
[TBL] [Abstract][Full Text] [Related]
11. Injection of corticosteroids, hyaluronate, and amikacin into the navicular bursa in horses with signs of navicular area pain unresponsive to other treatments: 25 cases (1999-2002).
Dabareiner RM; Carter GK; Honnas CM
J Am Vet Med Assoc; 2003 Nov; 223(10):1469-74. PubMed ID: 14627099
[TBL] [Abstract][Full Text] [Related]
12. The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
Back W; MacAllister CG; van Heel MC; Pollmeier M; Hanson PD
Equine Vet J; 2009 Mar; 41(3):309-12. PubMed ID: 19469242
[TBL] [Abstract][Full Text] [Related]
13. Influence of intravenous regional limb perfusion with amikacin sulfate on Staphylococcus aureus bioburden in distal limb wounds in horses.
Freeland RB; Morello SL; DeLombaert M; Rajamanickam V
Vet Surg; 2017 Jul; 46(5):663-674. PubMed ID: 28256725
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of podotrochlear (navicular) bursa injections for signs of foot pain in horses evaluated via magnetic resonance imaging: 23 cases (2005-2007).
Bell CD; Howard RD; Taylor DS; Voss ED; Werpy NM
J Am Vet Med Assoc; 2009 Apr; 234(7):920-5. PubMed ID: 19335243
[TBL] [Abstract][Full Text] [Related]
15. Comparison of an inertial sensor system with a stationary force plate for evaluation of horses with bilateral forelimb lameness.
Keegan KG; MacAllister CG; Wilson DA; Gedon CA; Kramer J; Yonezawa Y; Maki H; Pai PF
Am J Vet Res; 2012 Mar; 73(3):368-74. PubMed ID: 22369528
[TBL] [Abstract][Full Text] [Related]
16. Effects of intrabursal administration of botulinum toxin type B on lameness in horses with degenerative injury to the podotrochlear apparatus.
Gutierrez-Nibeyro SD; Santos MP; White NA; Brown JA; Adams MN; McKnight AL; Schaeffer DJ
Am J Vet Res; 2014 Mar; 75(3):282-9. PubMed ID: 24564314
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness.
Hu HH; MacAllister CG; Payton ME; Erkert RS
J Am Vet Med Assoc; 2005 Feb; 226(3):414-7. PubMed ID: 15702692
[TBL] [Abstract][Full Text] [Related]
18. Association between subjective lameness grade and kinetic gait parameters in horses with experimentally induced forelimb lameness.
Ishihara A; Bertone AL; Rajala-Schultz PJ
Am J Vet Res; 2005 Oct; 66(10):1805-15. PubMed ID: 16273915
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of clodronic acid in horses diagnosed with navicular syndrome: A field study using objective and subjective lameness evaluation.
Argüelles D; Saitua A; de Medina AS; Muñoz JA; Muñoz A
Res Vet Sci; 2019 Aug; 125():298-304. PubMed ID: 31351199
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutazone concentrations in synovial fluid following administration via intravenous regional limb perfusion in the forelimbs of six adult horses.
O'Brien M; Mochel JP; Kersh K; Wang C; Troy J
Front Vet Sci; 2023; 10():1236976. PubMed ID: 37691633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]